{
  "_comment": "Example assumptions override file. Copy to overrides.json and customize.",

  "incidence": 300000,
  "prevalence": 3800000,

  "treated_rate": 0.85,

  "subtype_shares": {
    "HER2_positive": 0.20,
    "HER2_negative_HR_positive": 0.65,
    "triple_negative": 0.15
  },

  "stage_shares": {
    "early": 0.65,
    "metastatic": 0.35
  },

  "line_shares": {
    "1L": 1.0,
    "2L": 0.45,
    "3L": 0.20
  },

  "time_on_treatment_months": {
    "1L": 18,
    "2L": 12,
    "3L": 8
  },

  "incidence_cagr": 0.005,

  "avg_weight_kg": 70,

  "vial_sizes": {
    "IV": [
      { "size_mg": 150, "is_single_dose": true },
      { "size_mg": 420, "is_single_dose": true }
    ],
    "SC": [
      { "size_mg": 600, "is_single_dose": true }
    ]
  },

  "wastage_policy": {
    "allow_multi_dose_sharing": false,
    "discard_leftover": true
  },

  "relative_dose_intensity": 0.95,

  "scenarios": {
    "base": {
      "incidence_cagr": 0.005,
      "treated_rate_multiplier": 1.0,
      "tot_multiplier": 1.0,
      "adoption_multiplier": 1.0
    },
    "low": {
      "incidence_cagr": 0.0,
      "treated_rate_multiplier": 0.9,
      "tot_multiplier": 0.9,
      "adoption_multiplier": 0.85
    },
    "high": {
      "incidence_cagr": 0.01,
      "treated_rate_multiplier": 1.1,
      "tot_multiplier": 1.1,
      "adoption_multiplier": 1.15
    }
  }
}
